Abstract:OBJECTIVE:To investigate the prokaryotic expression of proteins pneumococcal endopeptidase O (PepO) and pneumococcal surface adhesin A (PsaA) in Streptococcus pneumoniae and their immunoprotective effect as vaccine candidate proteins.METHODS:Specific primers of target gene fragments were designed, and then PCR amplification was performed to establish recombinant plasmids pET28a(+)-pepO and pET28a(+)-psaA, which were transformed into host cells, Escherichia coli BL21 and DE3, respectively, to induce expression. Highly purified target proteins PepO and PsaA were obtained after purification. Mucosal immunization was performed for BALB/c mice and specific antiserum was prepared. ELISA was used to measure the antibody titer, and Western blot was used to analyze the specificity of the antiserum of target proteins. The mice were randomly divided into negative control group, PepO group, PsaA group, and PepO+PsaA combined immunization group, with 18 mice in each group. The models of different serotypes of Streptococcus pneumoniae infection were established to evaluate the immunoprotective effect of target proteins used alone or in combination.RESULTS:The target proteins PepO and PsaA were successfully obtained and Western blot demonstrated that the antiserum of these proteins had good specificity. There was no significant difference in the titers of IgA in saliva and IgG in serum between the PepO group and the combined immunization group (P>0.05); however, these two groups had significantly higher antibody titers than the PsaA group (P<0.05). The PepO, PsaA, and combined immunization groups had significantly higher protection rates for mice infected with Streptococcus pneumoniae D39 and CMCC31436 in the nasal cavity than the negative control group (P<0.05). The PepO and combined immunization groups had a significantly higher protection rate for mice infected with Streptococcus pneumoniae D39 than the PsaA group (P<0.05). The results of colonization experiment showed that compared with the control group, the PepO, PsaA, and combined immunization groups showed a significant reduction in the colonization of Streptococcus pneumoniae (CMCC31693 and CMCC31207) in the nasopharynx and lung (P<0.05). The combined immunization group showed a better effect on reducing the colonization of CMCC31207 in the lung than the PepO and PsaA alone groups.CONCLUSIONS:Combined PepO/PsaA vaccines may produce a better protective effect by mucosal immunization compared with the vaccine used alone in mice. The combined vaccines can effectively reduce the colonization of Streptococcus pneumoniae in the nasopharynx and lung. Therefore, such protein vaccines may have a great potential for research and development.

Immunization With A Zmpb-Based Protein Vaccine Could Protect Against Pneumococcal Diseases In Mice

Mucosal Immunization with Caseinolytic Protease X Elicited Cross-Protective Immunity Against Pneumococcal Infection in Mice.

Protection Elicited by Nasal Immunization with Pneumococcal Surface Protein A (pspa) Adjuvanted with Bacterium-Like Particles Against Streptococcus Pneumoniae Infection in Mice

Immunization With A Combination Of Three Pneumococcal Proteins Confers Additive And Broad Protection Against Streptococcus Pneumoniae Infections In Mice

Mucosal Immunization with Purified ClpP Could Elicit Protective Efficacy Against Pneumococcal Pneumonia and Sepsis in Mice

Protection Against Pneumococcal Infection Elicited By Immunization With Glutamyl Trna Synthetase, Polyamine Transport Protein D And Sortase A

A Novel PspA Protein Vaccine Intranasal Delivered by Bacterium-Like Particles Provides Broad Protection Against Pneumococcal Pneumonia in Mice

[Immunoprotective Effect of Combined Pneumococcal Endopeptidase O and Pneumococcal Surface Adhesin A Vaccines Against Streptococcus Pneumoniae Infection].

Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion

Mucosal Immunization with ClpP Could Protect Mice from Pneumococcal Pneumonia and Sepsis

Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection

Small Protein A and Phospholipase D Immunization Serves a Protective Role in a Mouse Pneumonia Model of Acinetobacter Baumannii Infection

Comparison Of Immunogenicity And Protection Of Two Pneumococcal Protein Vaccines Based On Psaa And Pspa

Immunogenicity and Efficacy of Serogroup A and D Bacterins Against Pasteurella Multocida in Mice

A Pneumococcal Vaccine Combination with Two Proteins Containing PspA Families 1 and 2 Can Potentially Protect Against a Wide Range of Streptococcus Pneumoniae Strains

T-B cell epitope peptides induce protective immunity against Mycoplasma pneumoniae respiratory tract infection in BALB/c mice

The experimental research of tne preparation for pneumococcal conjugate vaccine using pneumolysin as a protein carrier and its immumogenicity in mice

Protective Efficacy of a Genetic Subunit Bacterin against Actinobacillus pleuropneumoniae in Mice

Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4

Novel Immunoprotective Proteins of Streptococcus Pneumoniae Identified by Opsonophagocytosis Killing Screen

Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice